Analysts expect UQM Technologies Inc (NYSEMKT:UQM) to report $-0.04 EPS on June, 6.They anticipate $0.02 EPS change or 100.00% from last quarter’s $-0.02 EPS. After having $-0.03 EPS previously, UQM Technologies Inc’s analysts see 33.33% EPS growth. About 170,569 shares traded. UQM Technologies Inc (NYSEMKT:UQM) has risen 6.45% since September 30, 2016 and is uptrending. It has underperformed by 4.21% the S&P500.
Mannkind Corporation (NASDAQ:MNKD) had a decrease of 1.53% in short interest. MNKD’s SI was 19.49M shares in May as released by FINRA. Its down 1.53% from 19.79 million shares previously. With 1.80 million avg volume, 11 days are for Mannkind Corporation (NASDAQ:MNKD)’s short sellers to cover MNKD’s short positions. About 7.03 million shares traded or 171.43% up from the average. MannKind Corporation (NASDAQ:MNKD) has declined 67.42% since September 30, 2016 and is downtrending. It has underperformed by 78.08% the S&P500.
Among 4 analysts covering Mannkind (NASDAQ:MNKD), 1 have Buy rating, 2 Sell and 1 Hold. Therefore 25% are positive. Mannkind had 8 analyst reports since August 3, 2015 according to SRatingsIntel. The stock of MannKind Corporation (NASDAQ:MNKD) has “Underperform” rating given on Wednesday, January 6 by RBC Capital Markets. The company was downgraded on Wednesday, September 9 by Piper Jaffray. RBC Capital Markets maintained the stock with “Outperform” rating in Monday, August 3 report. Vetr downgraded the shares of MNKD in report on Friday, August 28 to “Strong-Buy” rating. RBC Capital Markets downgraded the stock to “Underperform” rating in Wednesday, November 4 report. Griffin Securities downgraded the shares of MNKD in report on Monday, November 16 to “Neutral” rating. Piper Jaffray maintained MannKind Corporation (NASDAQ:MNKD) rating on Wednesday, January 6. Piper Jaffray has “Underweight” rating and $0.05 target. The firm has “Underperform” rating by RBC Capital Markets given on Tuesday, May 10.
MannKind Corporation is a biopharmaceutical company. The company has market cap of $143.17 million. The Firm is focused on the discovery and development of therapeutic products for diseases, such as diabetes. It has a 0.94 P/E ratio. The Company’s product candidate is AFREZZA, which is an inhaled insulin used to control high blood sugar in adults with type I and type II diabetes and helps in glycemic control.
Investors sentiment increased to 1.65 in Q4 2016. Its up 0.36, from 1.29 in 2016Q3. It improved, as 17 investors sold MannKind Corporation shares while 26 reduced holdings. 22 funds opened positions while 49 raised stakes. 87.16 million shares or 5.24% less from 91.98 million shares in 2016Q3 were reported. Geode Capital Mgmt Ltd Liability Corporation holds 2.31 million shares or 0% of its portfolio. Sandy Spring Fincl Bank has invested 0% of its portfolio in MannKind Corporation (NASDAQ:MNKD). Deutsche Commercial Bank Ag invested in 0% or 211,663 shares. One Trading Limited Partnership reported 0.01% of its portfolio in MannKind Corporation (NASDAQ:MNKD). Guggenheim Cap Llc has 0% invested in MannKind Corporation (NASDAQ:MNKD). Citadel Lc holds 0% of its portfolio in MannKind Corporation (NASDAQ:MNKD) for 188,756 shares. Wealthtrust Fairport Limited Liability Corporation reported 16,978 shares. Hsbc Public Limited Company accumulated 55,861 shares. Zwj Counsel holds 0% or 15,000 shares in its portfolio. Nationwide Fund Advsr has invested 0% in MannKind Corporation (NASDAQ:MNKD). Bnp Paribas Arbitrage Sa stated it has 20,581 shares. First Allied Advisory Serv owns 138,707 shares. 54,414 were reported by Metropolitan Life Insur. Proshare Advisors Limited Liability Corp holds 52,088 shares. Spot Trading Ltd Llc stated it has 34,376 shares or 0% of all its holdings.
Investors sentiment decreased to 0.56 in 2016 Q4. Its down 1.44, from 2 in 2016Q3. It is negative, as 1 investors sold UQM Technologies Inc shares while 8 reduced holdings. 1 funds opened positions while 4 raised stakes. 4.55 million shares or 10.01% more from 4.13 million shares in 2016Q3 were reported. New Jersey-based Kcg Hldg has invested 0% in UQM Technologies Inc (NYSEMKT:UQM). 27,678 are owned by Susquehanna Int Gp Ltd Liability Partnership. Wells Fargo Communication Mn holds 0% or 89,000 shares. Prescott Grp Capital Mgmt Limited Liability Company holds 446,863 shares. Goldman Sachs Group Inc Inc has invested 0% in UQM Technologies Inc (NYSEMKT:UQM). Manufacturers Life The owns 3,090 shares or 0% of their US portfolio. Eidelman Virant reported 20,000 shares. Raymond James Financial Ser Advsrs holds 0% or 224,266 shares. Bank Of Ny Mellon owns 56,357 shares or 0% of their US portfolio. Morgan Stanley stated it has 0% in UQM Technologies Inc (NYSEMKT:UQM). Blackrock Fund Advisors invested in 11,473 shares. Blackrock Institutional Trust Na accumulated 1.50M shares or 0% of the stock. Group One Trading Lp invested 0% in UQM Technologies Inc (NYSEMKT:UQM). Pnc Services Gru holds 10,000 shares or 0% of its portfolio. Cranbrook Wealth Management Ltd Co has 3,000 shares for 0% of their portfolio.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.